ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to…
Browsing: advanced ovarian cancer
Deaths from ovarian cancer decline worldwide due to oral contraceptive use
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue…